Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA extends Fosrenol review

July 22, 2004

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Phase II protocol for NX-1207 accepted by FDA

July 19, 2004

Zonagen reports Androxal phase I/II study results

July 19, 2004

Atorvastatin improves erectile function in men with hypercholesterolemia-related ED

July 19, 2004

European marketing authorization for Vesicare for overactive bladder

July 12, 2004

Aminoalcohol derivatives for the treatment of urinary incontinence

July 9, 2004

NexMed and Schering AG sign Alprox-TD agreement

July 8, 2004

BioXell acquires from Roche rights to new indications for BXL-628

July 6, 2004

Vasopressin V2 receptor antagonist effective aquaretic in vivo

July 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...